Qian Huang joined Reistone in 2019 as Executive Director, Head of Clinical Operations. Qian has about 15 years experiences in clinical development across therapeutic areas in oncology, cardiovascular, respiratory and infectious diseases.
Before joining Reistone, Qian has worked in MSD R&D as head of clinical project management where she built up and strengthened the clinical operation expertise and project management capacities for PhI-IV studies. And prior to that she worked in Roche as global studies leader to start the global study management presence and outreach across US and Asia pacific regions.
Qian holds a master degree in pharmacology from Medical school, Fudan University in China.